PRA Health Sciences anuncia el nombramiento de un nuevo consejero
September 16, 2020 15:31 ET
|
PRA Health Sciences, Inc.
RALEIGH, Carolina del Norte, Sept. 16, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ:PRAH) ha anunciado hoy el nombramiento de Glen Stettin, doctor en medicina, como consejero del...
PRA 헬스사이언스, 신임 이사회 임원 선임
September 16, 2020 15:31 ET
|
PRA Health Sciences, Inc.
미국 노스캐롤라이나주 롤리, Sept. 17, 2020 (GLOBE NEWSWIRE) -- PRA 헬스사이언스(PRA Health Sciences, Inc. (NASDAQ:PRAH))는 글렌 스테틴(Glen Stettin, 일반의)이 2020년 9월 14일부로 이사회 임원으로 선임됐다고 발표했다. 콜린 섀넌(Colin Shannon) PRA...
PRA Health Sciences gibt Ernennung eines neuen Verwaltungsratsmitglieds bekannt
September 16, 2020 15:31 ET
|
PRA Health Sciences, Inc.
RALEIGH, North Carolina, Sept. 16, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) hat heute die Ernennung von Dr. Glen Stettin zum Verwaltungsratsmitglied des Unternehmens mit...
PRA Health Sciences annonce la nomination d'un nouveau directeur
September 16, 2020 15:31 ET
|
PRA Health Sciences, Inc.
RALEIGH, Caroline du Nord, 16 sept. 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ : PRAH) a annoncé aujourd'hui la nomination de Glen Stettin, M.D., au conseil d'administration de la...
PRA Health Sciences 宣佈委任新董事
September 16, 2020 15:31 ET
|
PRA Health Sciences, Inc.
北卡羅萊納州羅利, Sept. 17, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ:PRAH) 今天宣佈委任 Glenn Stettin 為公司董事會成員，並於 2020 年 9 月 14 日生效。 PRA health Sciences 董事會主席兼行政總裁 Colin Shannon 說：「我們很高興看到 Glen...
PRA Health Sciences Announces Appointment of New Director
September 15, 2020 16:02 ET
|
PRA Health Sciences, Inc.
RALEIGH, N.C., Sept. 15, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ:PRAH) today announced the appointment of Glen Stettin, M.D. to the Board of Directors of the Company, effective...
PRA Health Sciences, Inc. Reports Second Quarter 2020 Results and Provides Third Quarter and Full Year 2020 Guidance
August 06, 2020 16:01 ET
|
PRA Health Sciences, Inc.
Net new business of $701.6 million; Net book-to-bill of 1.35 excluding reimbursement revenueNet new business of $1,083.3 million; Net book-to-bill of 1.62 including reimbursement revenue$729.9 million...
PRA Health Sciences to Report Second Quarter 2020 Earnings
July 02, 2020 13:20 ET
|
PRA Health Sciences, Inc.
RALEIGH, N.C., July 02, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) will release its second quarter 2020 results after the market closes on Thursday, August 6, 2020. The...
PRA Health Sciences pronta para navegar nos requisitos da RACE Act de oncologia pediátrica
June 18, 2020 16:54 ET
|
PRA Health Sciences, Inc.
RALEIGH, N.C., June 18, 2020 (GLOBE NEWSWIRE) -- Entre 2007-2017, 78 novos agentes para câncer de adultos foram aprovados pela Food and Drug Administration dos EUA,1 mas nenhum desses medicamentos...
PRA 헬스사이언스, RACE 법 발효 앞두고 소아암 연구 역량 강화
June 18, 2020 16:54 ET
|
PRA Health Sciences, Inc.
미국 노스캐롤라이나주 롤리, June 19, 2020 (GLOBE NEWSWIRE) -- 2007년부터 2017년까지 미국 FDA(식품의약국)가 승인한 성인용 신약 항암제는 총 78종이다1. 그러나 이 가운데 소아암 환자에 대한 효능이 연구된 약은 단 하나도 없다. 오는 8월 18일 RACE(어린이 신약 및 형평 증진 연구) 법이 발효되면 이 같은...